跳至主要内容
临床试验/CTRI/2025/12/099861
CTRI/2025/12/099861尚未招募不适用

ASSOCIATION OF GHRELIN GENE (GHRL) POLYMORPHISM (rs4684677) WITH COGNITIVE STATUS IN T2DM

Maulana Azad Medical College1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年1月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
试验地点
1

研究概览

简要总结

The primary aim is to detect GHRL rs4684677 polymorphism and measure plasma ghrelin levels alongside cognitive function in T2DM patients versus controls. T2DM drives cognitive decline via insulin resistance and inflammation, with ghrelin offering neuroprotective potential. This study links genetic variation, hormone levels, and MoCA-assessed cognition to elucidate early DCI mechanisms

研究设计

研究类型
Observational

入排标准

年龄范围
35.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • For Cases:Known diabetic patients diagnosed with T2DM,atleast for the last 5 years as per ADA criteria.On treatment,without any other known metabolic,surgical,or psychiatric comorbid condition.
  • For Control:Healthy volunteers.

排除标准

  • For Cases: Patient admitted with acute complications of Diabetes mellitus.
  • For Control: history of any substance abuse which may affect cognitive function.

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Smita Kaushik

Maulana Azad Medical College

研究点 (1)

Loading locations...

相似试验